Author

I. Y. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:organoid / primary culture· 1 Approach:statistical model· 1

Frequent Co-Authors

G. Palapattu· 1 shared G. T. lee· 1 shared J. W. Choi· 1 shared M. B. Heo· 1 shared M. Kwak· 1 shared S.-H. Bae· 1 shared T. G. Lee· 1 shared W. T. Kim· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

G. Palapattu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Testing in vitro toxicity of nanoparticles in 3D cell culture with various extracellular matrix scaffold

J. W. Choi, S.-H. Bae, I. Y. Kim, M. Kwak, T. G. Lee, M. B. Heo

This study compares the toxicity of 20 nm SiO2 nanoparticles in 2D and 3D cell cultures using different scaffolds, finding reduced toxicity in 3D cultures and scaffold-dependent effects in serum-free conditions.

bioRxiv · Mar 18, 2021 · PreprintPharmacology & Toxicology

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer

G. T. lee, W. T. Kim, Y. S. Kwon, G. Palapattu, W.-J. Kim, I. Y. Kim

This study identifies TCF4 as a driver of enzalutamide resistance in prostate cancer through neuroendocrine differentiation.

bioRxiv · Feb 25, 2019Cancer Biology